![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Southwest Synthetic Pharmaceutical Corporation, Limited Chongqing Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Simvastatin, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2010-116 - Rev 00
This Chemical Type CEP, issued on June 12, 2017, remains in force until May 21, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes